Multimerization of ERBB2/HER2 specific aptamer leads to improved receptor binding.

Area of Science:

• Biochemistry
• Molecular Biology
• Biophysics

Background:

• Aptamers are emerging as a novel therapeutic strategy for cancer treatment.
• Key aptamer characteristics include specificity and high affinity for target molecules.

Purpose of the Study:

• To elucidate physicochemical parameters of an ERBB2/HER2 specific aptamer.
• To determine the optimal multimerization state for enhanced binding and avidity.
• To assess the immunogenicity of the optimized aptamer.

Main Methods:

• Biochemical assays
• Immunochemical techniques
• Biophysical methodologies
• In vivo studies

Main Results:

• Characterized binding behaviors of multimerized ERBB2/HER2 aptamers.
• Demonstrated structural integrity of multimerized aptamers.
• Confirmed no in vivo immunogenic response for the trimeric aptamer.

Conclusions:

• Multimerization enhances the binding and avidity of ERBB2/HER2 aptamers.
• The trimeric aptamer is a potent and safe therapeutic candidate.
• Developed a methodology to improve aptamer activity for cancer therapy.